Karyopharm Therapeutics
KPTI
KPTI
146 hedge funds and large institutions have $1.13B invested in Karyopharm Therapeutics in 2019 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+40
Holders Change %
+37.74%
% of All Funds
2.88%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.1%
New
52
Increased
41
Reduced
39
Closed
11
Calls
$16.5M
Puts
$15.6M
Net Calls
+$838K
Net Calls Change
+$955K
Top Buyers
1 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$40M |
2 |
D.E. Shaw & Co
New York
|
+$18.9M |
3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$15.7M |
4 |
Two Sigma Investments
New York
|
+$14M |
5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$6.76M |